Specifically, in the case of loss of Tsc1/2 function, use of ER stress-inducing agents has displayed sensitization of mutant cells to individual treatments in vitro (Kang et al., 2011), or combination treatments in a mouse xenograft tumor model (Li et al., 2015). Here, TSC1 is linked to neoplasm.